Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

14
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
14
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Antibiotic Selection00:57

Antibiotic Selection

54.3K
Overview
54.3K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

23
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
23
Pharmacovigilance01:19

Pharmacovigilance

857
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
857

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.

The Lancet. Microbe·2026
Same author

Persistent spread of carbapenemase-producing Klebsiella pneumoniae in acute care hospitals in 36 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.

The Lancet. Microbe·2026
Same author

Applying a gender and equity matrix for a contextualized antimicrobial stewardship intervention in Pakistan.

Health policy and planning·2026
Same author

Spotlight commentary: Deprescribing in long-term care facilities-Towards safer and smarter medication use in older adults.

British journal of clinical pharmacology·2026
Same author

From structured surveys to outbreak investigations: advancing genomic surveillance of carbapenem-resistant Enterobacterales within the European Antimicrobial Resistance Genes Surveillance Network.

Frontiers in public health·2025
Same author

Multi-country surveillance of paediatric invasive group A <i>Streptococcus</i> infection, European Union/European Economic Area countries, 2022/23 season.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025
Same journal

Author's correction for Euro Surveill. 2026;31(24).

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Dermatophilosis among men who have sex with men, Stockholm, Sweden, March to June, 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Population-based prevalence and screening gaps of hepatitis C, B and D, Germany, 2020 to 2021.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Ongoing multi-country outbreak of carbapenem-resistant <i>Enterobacter hormaechei</i> ST1344 carrying <i>bla</i> <sub>NDM-5</sub> in the European Union/European Economic Area, March 2025 to April 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Detection of antibodies against avian influenza in European dairy cattle, the Netherlands, January 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

First steps in establishing surveillance of bloodstream infections from electronic health record derived data, EU/EEA countries, March 2023 to March 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.9K

Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022.

Cèlia Ventura-Gabarró1, Vivian H Leung1, Vera Vlahović-Palčevski2

  • 1European Centre for Disease Prevention and Control, Solna, Sweden.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|November 16, 2023
PubMed
Summary
This summary is machine-generated.

Community consumption of systemic antibacterials (ATC J01) rebounded in the EU/EEA during 2021-2022, returning to pre-pandemic levels. This trend may indicate a missed opportunity for promoting prudent antibiotic use.

Keywords:
Antimicrobial consumptionCOVID-19 pandemicEU/EEAantibiotic consumption

More Related Videos

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

6.5K
Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli
12:29

Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli

Published on: March 24, 2023

2.0K

Related Experiment Videos

Last Updated: Jul 11, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.9K
Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

6.5K
Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli
12:29

Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli

Published on: March 24, 2023

2.0K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibacterial consumption decreased in the EU/EEA between 2019 and 2020.
  • The COVID-19 pandemic influenced healthcare practices and disease transmission patterns.

Purpose of the Study:

  • To analyze trends in antibacterial consumption in the community sector of the EU/EEA.
  • To assess whether the decrease in antibacterial use during the pandemic was sustained.
  • To evaluate the implications for antimicrobial stewardship.

Main Methods:

  • Analysis of sales data for antibacterials for systemic use (ATC J01).
  • Comparison of consumption rates between 2019 and 2022 across EU/EEA countries.
  • Assessment of trends following the initial decrease observed in 2020.

Main Results:

  • A rebound in antibacterial consumption was observed in 2021 and 2022.
  • Consumption rates in 2022 returned to pre-COVID-19 pandemic levels.
  • Thirteen countries exceeded their pre-pandemic antibacterial consumption rates in 2022.

Conclusions:

  • The rebound in antibacterial use suggests a potential loss of progress in antimicrobial stewardship.
  • Changes in disease transmission may partly explain the observed patterns.
  • Reinforcing prudent antibiotic use remains critical despite pandemic-related fluctuations.